Catalent

Acquired

Leading Global CDMO Pharma Solutions

Catalent is a biotech company in United States, founded in 2007.

Headquarters
New Jersey
Employees
10001+
Founded
2007
Business Model
B2B
Acquisition Date
Jan 2024

Indexed holds 1 investor for this company. to use credits for reveals, or explore the API.

About

Catalent partners with pharmaceutical, biotechnology, and consumer health companies to develop, manufacture, and deliver medicines, therapies, and other products. Its integrated services span small molecules, biologics, cell and gene therapies, and clinical supply. The company supports customers from early-stage design through commercial manufacturing, combining advanced technologies, global scale, and technical expertise.

Exit History

Data from Indexed.vcUpdated
AcquisitionJan 2024

1 more event

  • IPO2014

Funding, valuations, and company events, with amounts and investors where available.

Investors

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Cloud/Infrastructure ×2
  • Other ×2
  • Engineering & DevOps ×1
  • Marketing & SEO ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Catalent on Indexed.vc
<a href="https://indexed.vc/companies/catalent"><img src="https://indexed.vc/api/badge/company/catalent" alt="Catalent on Indexed.vc" width="260" height="76" /></a>